Telit and Controlant have produced close to one million cellular cold-chain data logger devices, powered by Telit IoT modules, to ensure efficient distribution and quality of billions of vaccine doses that one of the world’s leading biopharmaceutical companies is distributing across the globe.

The two organisations are also partnering to introduce new LPWA/LTE-M global technology into Controlant’s next generation of last-mile temperature logger devices.

COVID-19 vaccines, in particular, must maintain strict temperature control along every mile of the supply chain to ensure quality and integrity.

“Controlant’s Cold Chain as a Service solution calls for global pay-as-you-go visibility with real-time tracking of data to provide mission-critical analytics to its customer base, and our partnership with Telit was instrumental to reach the relevant ramp-up quantity to secure continued distribution of the vaccine to all parts of the world,” said Erlingur Brynjulfsson, CTO, Controlant. “By extending the relationship with Telit, Controlant will implement Global enabled LTE-M LPWA modem technology, which will pave Controlant’s path to 5G IoT in the coming years. While serving different vertical market segments, it will ensure our ability to run the highest level of quality service for the next decade in any corner of the world.”

“Despite a period of severe material shortages and production challenges during various waves of virus outbreaks and regional lock-downs, Telit and its suppliers and production partners engaged in unprecedented collaboration to deliver all vaccine units in record time and enable the vaccination campaigns to be implemented without any disruption in the supply,” said Martin Krona, SVP, EMEA, Telit. “Now, during a time of rapidly-changing cellular ecosystem and infrastructure, we are very pleased to collaborate with Controlant’s R&D and product teams to include Telit module technologies that will be supported globally for the next decade during the migration from 4G to 5G and beyond.”